Trial Scorecards

Trial Scorecards

Issue: November 2017
November 08, 2017
1 min read
Save

Trial Scorecard: PACIFY

Issue: November 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study evaluated effects of anacetrapib (Merck) to reduce risk for MI, coronary death or coronary revascularization in patients with atherosclerotic vascular disease taking statin therapy.

Trial Scorecard: PACIFY